Annual Accounts Receivable
$358.00M$534.00M-59.87%
Summary
- Current Value
- As of today, MRNA annual accounts receivable is $358.00M, down -59.87% on
- Historical Performance
- MRNA annual accounts receivable is down -88.72% over the past 3 years, and up +6567.91% over the past 5 years
- All-Time High Comparison
- MRNA annual accounts receivable is currently -88.72% below its historical high of $3.18B set on
- 3-Year Low Comparison
- MRNA annual accounts receivable is at its 3-year low
- Sector Comparison
- MRNA annual accounts receivable is higher than 84.24% of companies in Healthcare sector
Annual Accounts Receivable Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Accounts Receivable | $358.00M | -59.9% | -88.7% | +6567.9% | +10000.0% | |
| Quarterly Accounts Receivable | $1.05B | -33.1% | -61.2% | +449.1% | +10000.0% | |
| Price | $39.60 | +12.7% | -79.4% | -68.1% | – | |
| Annual Accounts Payable | $405.00M | -22.1% | +34.1% | +5612.3% | +10000.0% | |
| Annual Current Assets | $8.10B | -21.6% | -49.6% | +617.5% | +10000.0% | |
| Annual Revenue | $3.24B | -52.7% | -82.4% | +5274.6% | +10000.0% | |
| Annual Net Income | -$3.56B | +24.5% | -129.2% | -592.8% | -10000.0% | |
| Annual Cash & Cash Equivalents | $1.93B | -33.7% | -71.9% | +717.0% | +10000.0% |
Annual Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.39B | N/A | -74.2% |
| 5Y | $3.18B | -88.7% | |
| All | $3.18B | -88.7% |
Annual Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $358.00M | at low | |
| 5Y | $358.00M | at low | |
| All | $0.00 | N/A |
Annual Accounts Receivable History
FAQ
What is the current annual accounts receivable of MRNA?
As of today, MRNA annual accounts receivable is $358.00M
What is 1-year change in MRNA annual accounts receivable?
MRNA annual accounts receivable is down -59.87% year-over-year
What is 3-year change in MRNA annual accounts receivable?
MRNA annual accounts receivable is down -88.72% over the past 3 years
How far is MRNA annual accounts receivable from its all-time high?
MRNA annual accounts receivable is currently -88.72% below its historical high of $3.18B set on December 31, 2021
How does MRNA annual accounts receivable rank versus sector peers?
MRNA annual accounts receivable is higher than 84.24% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly Accounts Receivable
$1.05B$1.01B+2,805.56%
Summary
- Current Value
- As of today, MRNA quarterly accounts receivable is $1.05B, up +2805.56% on
- Historical Performance
- MRNA quarterly accounts receivable is down -33.12% year-over-year, and down -61.19% over the past 3 years
- All-Time High Comparison
- MRNA quarterly accounts receivable is currently -67.41% below its historical high of $3.21B set on
- 3-Year Low Comparison
- MRNA quarterly accounts receivable is +2805.56% above its 3-year low of $36.00M reached on
- Sector Comparison
- MRNA quarterly accounts receivable is higher than 92.43% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Accounts Receivable | $1.05B | +2805.6% | -33.1% | -61.2% | +449.1% | |
| Annual Accounts Receivable | $358.00M | – | -59.9% | -88.7% | +6567.9% | |
| Price | $39.60 | +48.1% | +12.7% | -79.4% | -68.1% | |
| Quarterly Accounts Payable | $267.00M | +52.6% | -28.4% | -19.1% | +1201.1% | |
| Quarterly Current Assets | $6.60B | +6.9% | -31.7% | -53.9% | +84.5% | |
| Quarterly Revenue | $1.02B | +615.5% | -45.4% | -69.3% | +543.4% | |
| Quarterly Net Income | -$200.00M | +75.8% | -1638.5% | -119.2% | +14.4% | |
| Quarterly Cash & Cash Equivalents | $4.51B | -12.2% | -34.4% | -46.0% | +37.5% |
Quarterly Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.05B | at high | |
| 3Y | $1.87B | -43.9% | |
| 5Y | $3.21B | -67.4% | |
| All | $3.21B | -67.4% |
Quarterly Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $36.00M | +2805.6% | |
| 3Y | $36.00M | +2805.6% | |
| 5Y | $36.00M | +2805.6% | |
| All | $0.00 | N/A |
Quarterly Accounts Receivable History
FAQ
What is the current quarterly accounts receivable of MRNA?
As of today, MRNA quarterly accounts receivable is $1.05B
What is MRNA quarterly accounts receivable most recent change?
MRNA quarterly accounts receivable was up +2805.56% on September 30, 2025
What is 1-year change in MRNA quarterly accounts receivable?
MRNA quarterly accounts receivable is down -33.12% year-over-year
How far is MRNA quarterly accounts receivable from its all-time high?
MRNA quarterly accounts receivable is currently -67.41% below its historical high of $3.21B set on March 31, 2021
How does MRNA quarterly accounts receivable rank versus sector peers?
MRNA quarterly accounts receivable is higher than 92.43% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna